JP2023535405A5 - - Google Patents

Info

Publication number
JP2023535405A5
JP2023535405A5 JP2023504251A JP2023504251A JP2023535405A5 JP 2023535405 A5 JP2023535405 A5 JP 2023535405A5 JP 2023504251 A JP2023504251 A JP 2023504251A JP 2023504251 A JP2023504251 A JP 2023504251A JP 2023535405 A5 JP2023535405 A5 JP 2023535405A5
Authority
JP
Japan
Prior art keywords
composition according
administration
cov
cancer
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023504251A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535405A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/042684 external-priority patent/WO2022020542A1/en
Publication of JP2023535405A publication Critical patent/JP2023535405A/ja
Publication of JP2023535405A5 publication Critical patent/JP2023535405A5/ja
Pending legal-status Critical Current

Links

JP2023504251A 2020-07-22 2021-07-22 呼吸器疾患に関連する状態の処置および防止 Pending JP2023535405A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063055165P 2020-07-22 2020-07-22
US63/055,165 2020-07-22
US202063060503P 2020-08-03 2020-08-03
US63/060,503 2020-08-03
US202063108980P 2020-11-03 2020-11-03
US63/108,980 2020-11-03
PCT/US2021/042684 WO2022020542A1 (en) 2020-07-22 2021-07-22 Treatment and prevention of conditions associated with respiratory diseases

Publications (2)

Publication Number Publication Date
JP2023535405A JP2023535405A (ja) 2023-08-17
JP2023535405A5 true JP2023535405A5 (cg-RX-API-DMAC10.html) 2025-04-17

Family

ID=79729865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023504251A Pending JP2023535405A (ja) 2020-07-22 2021-07-22 呼吸器疾患に関連する状態の処置および防止

Country Status (5)

Country Link
US (1) US20230270845A1 (cg-RX-API-DMAC10.html)
EP (1) EP4185272A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023535405A (cg-RX-API-DMAC10.html)
CA (1) CA3186799A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022020542A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025504814A (ja) * 2022-01-21 2025-02-19 ユニバーシティー オブ ヒューストン システム 呼吸器疾患のための経鼻ワクチンおよび治療剤
CN114712304B (zh) * 2022-04-18 2024-03-12 深圳大学 海藻酸钠基复合水凝胶的制备方法
WO2025194158A1 (en) * 2024-03-15 2025-09-18 University Of Houston System Mucosal vaccines against respiratory syncytial virus
WO2025199149A1 (en) * 2024-03-18 2025-09-25 Cour Pharmaceuticals Development Company Inc. Sting agonism for antigen specific tolerance
CN120459057B (zh) * 2025-06-06 2026-04-14 上海大学 一种单核细胞搭载型产氧脂质体及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8080642B2 (en) * 2003-05-16 2011-12-20 Vical Incorporated Severe acute respiratory syndrome DNA compositions and methods of use
KR102483033B1 (ko) * 2016-05-16 2022-12-30 액세스 투 어드밴스드 헬스 인스티튜트 페길화된 리포솜 및 이의 용도
EP3471778A4 (en) * 2016-06-20 2020-02-19 The Regents of The University of Michigan COMPOSITIONS AND METHOD FOR DELIVERING BIOMACROMOLECOLIC ACTIVE SUBSTANCES
KR101982710B1 (ko) * 2017-03-17 2019-05-28 주식회사 큐라티스 스팅 작용자를 포함하는 면역항원보강제 및 백신 조성물
TW202003032A (zh) * 2018-03-23 2020-01-16 美商科迪亞克生物科學公司 包含s t i n g 促效劑之胞外囊泡

Similar Documents

Publication Publication Date Title
CN110520438A (zh) 溶瘤病毒疗法
JP7672657B2 (ja) 核酸脂質粒子ワクチン
CN106459998A (zh) 预防或治疗慢性乙型肝炎病毒(hbv)感染的基于病毒样囊泡(vlv)的疫苗
CN111154806A (zh) 一种嵌合外源超级细胞因子的溶瘤病毒载体系统及其在药物中的应用
AU2022422532A1 (en) Immunostimulatory mrna compositions and uses thereof
CN116200394A (zh) CpG寡聚脱氧核苷酸及其应用
AU2023307031A1 (en) Recombinant oncolytic virus and use thereof
CN117298264A (zh) 基于流感病毒ha蛋白和新冠病毒s蛋白的组合物和疫苗
Zhang et al. mRNA-encoded mutant HPV16/18 vaccines promote specific T-cell responses and synergize with anti-PD-1 checkpoint blockade in mediating therapeutic tumor regression in mice
CN116568309B (zh) 一种用于预防或治疗慢性乙型肝炎的药物组合制剂及其用途以及组合制剂试剂盒
CN105797147B (zh) Cxcl13 dna疫苗及其应用
CN115804853A (zh) 包含rna分子的组合物及其在制备瘤内注射剂中的用途
CN104768575B (zh) 含有vegf特异性表位和/或血管生成素‑2特异性表位的dna疫苗
KR102673991B1 (ko) 경비 b형 간염 백신 조성물 및 그 제조방법
EP3713600B1 (en) Synthetic hemagglutinin as universal vaccine against infection by type b influenza viruses (ibv)
CN106075432A (zh) 皮卡钙联合佐剂及含有皮卡钙联合佐剂的疫苗
CN110139875B (zh) Col14a1衍生的肿瘤抗原多肽及其应用
JP2023549675A5 (cg-RX-API-DMAC10.html)
Nam et al. Modulation of immune response induced by co-administration of DNA vaccine encoding HBV surface antigen and HCV envelope antigen in BALB/c mice
JPWO2010109706A1 (ja) 分子標的薬に対する感受性が低下している癌の治療薬および分子標的薬に対する感受性を増強する医薬組成物
CN116621966B (zh) 治疗性核酸分子、混合物、药物及在治疗实体瘤中的应用
US20220370581A1 (en) Vaccine and method for treating cancer
CA3141323C (en) Recombinant interleukin 12 construct and uses thereof
US20230390384A1 (en) Recombinant covid-19 vaccine composition comprising lipopeptide and poly (i:c) adjuvant, and use thereof
KR101293363B1 (ko) 인터페론 수용체 유전자를 포함하는 조류독감 예방용 조성물